WALTHAM, Mass., April 22, 2015 (GLOBE NEWSWIRE) -- TESARO, Inc. TSRO, an oncology-focused biopharmaceutical company, today announced its participation in three investor conferences during the month of May, including:
- The Mizuho Securities USA Third Annual Healthcare Corporate Access Day in New York City on Tuesday, May 5, 2015;
- The Citi Midwest Healthcare Access Day in Chicago on Tuesday, May 5, 2015; and
- The Deutsche Bank 40th Annual Health Care Conference at the Intercontinental Hotel in Boston, May 6-7, 2015. Lonnie Moulder, CEO, and Mary Lynne Hedley, Ph.D., President and COO of TESARO, are scheduled to present an overview of TESARO's business and development programs at 2:10 PM ET on Thursday, May 7. A live webcast will be available by visiting the Investors section of the TESARO website at www.tesarobio.com. An archived replay of the webcast will be available on the Company's website for 14 days after the conference.
About TESARO
TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.
CONTACT: For additional information, please contact:
Jennifer Davis
1.781.325.1116
jdavis@tesarobio.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: Press Releases
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in